tradingkey.logo

BioLife Solutions Inc

BLFS
22.430USD
+0.410+1.86%
종가 02/06, 16:00ET시세는 15분 지연됩니다
1.08B시가총액
손실P/E TTM

BioLife Solutions Inc

22.430
+0.410+1.86%

자세한 내용은 BioLife Solutions Inc 회사

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

BioLife Solutions Inc 정보

종목 코드 BLFS
회사 이름BioLife Solutions Inc
상장일Nov 22, 1989
CEODe Greef (Roderick)
직원 수159
유형Ordinary Share
회계 연도 종료Nov 22
주소Suite 310
도시BOTHELL
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호98021
전화14254011400
웹사이트https://www.biolifesolutions.com/
종목 코드 BLFS
상장일Nov 22, 1989
CEODe Greef (Roderick)

BioLife Solutions Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
251.85K
-405.00%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
149.25K
-335.00%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
66.72K
-990.00%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
48.80K
-241.00%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-3000.00%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-110.00%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
251.85K
-405.00%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
149.25K
-335.00%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
66.72K
-990.00%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
48.80K
-241.00%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-3000.00%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-110.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Product Revenue-Cell processing
25.28M
90.08%
Rental Revenue- Evo and thaw
1.79M
6.38%
Product Revenue- Evo and thaw
968.00K
3.45%
Service Revenue-Evo and thaw
26.00K
0.09%
지역별USD
이름
수익
비율
United States
21.33M
76.00%
Europe & Middle East & Africa (EMEA) (Region)
5.33M
19.00%
Other Countries
1.40M
5.00%
사업별
지역별
사업별USD
이름
수익
비율
Product Revenue-Cell processing
25.28M
90.08%
Rental Revenue- Evo and thaw
1.79M
6.38%
Product Revenue- Evo and thaw
968.00K
3.45%
Service Revenue-Evo and thaw
26.00K
0.09%

주식 보유 통계

마지막 업데이트: Sat, Nov 15
마지막 업데이트: Sat, Nov 15
주주
주주 유형
주주
주주
비율
Casdin Capital, LLC
12.37%
T. Rowe Price Investment Management, Inc.
10.76%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.40%
기타
52.65%
주주
주주
비율
Casdin Capital, LLC
12.37%
T. Rowe Price Investment Management, Inc.
10.76%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.40%
기타
52.65%
주주 유형
주주
비율
Investment Advisor
52.44%
Investment Advisor/Hedge Fund
34.07%
Hedge Fund
15.54%
Research Firm
2.31%
Individual Investor
1.99%
Pension Fund
1.60%
Bank and Trust
0.48%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
402
49.86M
109.33%
-743.44K
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Casdin Capital, LLC
5.96M
12.37%
-750.00K
-11.18%
Oct 15, 2025
T. Rowe Price Investment Management, Inc.
4.07M
8.45%
-179.85K
-4.24%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.10M
10.6%
+21.37K
+0.42%
Sep 30, 2025
Invesco Advisers, Inc.
3.48M
7.22%
+21.52K
+0.62%
Sep 30, 2025
The Vanguard Group, Inc.
2.96M
6.15%
+70.25K
+2.43%
Sep 30, 2025
State Street Investment Management (US)
1.46M
3.03%
+47.61K
+3.38%
Sep 30, 2025
Fred Alger Management, LLC
1.11M
2.3%
-139.11K
-11.15%
Sep 30, 2025
Fidelity Management & Research Company LLC
1.02M
2.11%
+1.01M
+35792.97%
Sep 30, 2025
Rockefeller Capital Management
1.01M
2.1%
-16.29K
-1.59%
Sep 30, 2025
MFS Investment Management
1.10M
2.28%
-4.74K
-0.43%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
더 보기
Invesco S&P SmallCap Health Care ETF
비율0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
비율0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
비율0.52%
Zacks Small/Mid Cap ETF
비율0.41%
iShares Micro-Cap ETF
비율0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
비율0.15%
First Trust Small Cap Growth AlphaDEX Fund
비율0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
비율0.14%
iShares S&P Small-Cap 600 Growth ETF
비율0.14%
iShares ESG Select Screened S&P Small-Cap ETF
비율0.09%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI